Geneos Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Geneos Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.8K	Hold	165	–	–	﹤0.01%	2168
2025 Q4	$4.33K	Buy	165 +1	+0.6%	+$26	﹤0.01%	2178
2025 Q3	$3.88K	Hold	164	–	–	﹤0.01%	2203
2025 Q2	$3.37K	Sell	164 -162	-50%	-$3.26K	﹤0.01%	2683
2025 Q1	$6.68K	Buy	+326	New	+$7.28K	﹤0.01%	2684

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Geneos Wealth Management's IDNA Position: Q1 2026 in Review

Geneos Wealth Management held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q1 2026 at 165 shares worth $4.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2168.

Geneos Wealth Management first reported a position in IDNA in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.68K in Q1 2025. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

Geneos Wealth Management held 165 shares of iShares Genomics Immunology and Healthcare ETF worth $4.8K as of Q1 2026.
Geneos Wealth Management left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q1 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2168 holding.
Geneos Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2025 and has held it in 5 quarters since.
Geneos Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $6.68K in Q1 2025.
60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.